Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Brimonidine for Asian Flushing Syndrome
NCT03497442Phase 1Completed
- Sponsor
- University of California, San Francisco
- Start
- Jul 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of brimonidine transdermal lotion in alcohol flush reaction (2 arms), sponsored by University of California, San Francisco. Primary endpoints: Clinician Erythema Assessment Score and Patient Erythema Self Assessment Score. Started Jul 2018; status: completed.
02
Drugs
brimonidine transdermal lotion
03
Conditions
alcohol flush reaction
Beyond the preview
Go deeper on NCT03497442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03497442.